Page last updated: 2024-11-13

ikarugamycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ikarugamycin: structure given in first source; an antiprotozoal antibiotic isolated from Streptomyces phaeochromogenes ikaruganensis; inhibits the uptake of oxidized LDL in macrophage J774 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ikarugamycin : A polyketide macrolactam containing a tetramic acid (pyrrolidine-2,4-dione) ring system. It is isolated from Streptomyces as an antibiotic with antiprotozoal and cytotoxic activities. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID54680304
CHEMBL ID4283254
CHEBI ID75276
MeSH IDM0200648

Synonyms (13)

Synonym
ikarugamycin
36531-78-9
CHEBI:75276
(2r,3r,3as,5ar,5bs,7z,14s,19e,20as,21ar,21br)-3-ethyl-22-hydroxy-2-methyl-2,3,3a,5a,5b,6,10,11,12,13,14,15,20a,21,21a,21b-hexadecahydro-1h-14,17-(metheno)-as-indaceno[3,2-k][1,6]diazacycloheptadecine-9,16,18(17h)-trione
AKOS030213232
mfcd01722005
HY-119764
DTXSID501017235
CS-0077951
MS-28900
CHEMBL4283254
nsc-789948
nsc789948

Research Excerpts

Overview

Ikarugamycin is a member of the polycyclic tetramate macrolactams (PTMs) family of natural products with diverse biological activities. It has been shown to inhibit the uptake of oxidized low-density lipoproteins in macrophages.

ExcerptReferenceRelevance
"Ikarugamycin is a member of the polycyclic tetramate macrolactams (PTMs) family of natural products with diverse biological activities. "( Mechanistic insights into polycycle formation by reductive cyclization in ikarugamycin biosynthesis.
Li, S; Ma, L; Shi, R; Shi, T; Zhang, C; Zhang, G; Zhang, H; Zhang, Q; Zhang, W; Zhao, YL; Zhu, Y, 2014
)
2.08
"Ikarugamycin (IKA) is a previously discovered antibiotic, which has been shown to inhibit the uptake of oxidized low-density lipoproteins in macrophages. "( Ikarugamycin: A Natural Product Inhibitor of Clathrin-Mediated Endocytosis.
Elkin, SR; MacMillan, JB; Mettlen, M; Oswald, NW; Reed, DK; Schmid, SL, 2016
)
3.32
"Ikarugamycin (IKA) is an antibiotic with strong antiprotozoal and cytotoxic activity. "( Ikarugamycin induces DNA damage, intracellular calcium increase, p38 MAP kinase activation and apoptosis in HL-60 human promyelocytic leukemia cells.
Dirsch, VM; Ferk, F; Heiss, EH; Knasmueller, S; Kopp, B; Krupitza, G; Peschel, A; Popescu, R, 2011
)
3.25
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1825649Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as inhibition of bacterial growth measured after 18 hrs by CLSI protocol based microbroth dilution method2022Journal of natural products, 01-28, Volume: 85, Issue:1
Multifunctional P450 Monooxygenase CftA Diversifies the Clifednamide Pool through Tandem C-H Bond Activations.
AID1825650Antibacterial activity against Staphylococcus aureus ATCC 11632 assessed as inhibition of bacterial growth measured after 18 hrs by CLSI protocol based microbroth dilution method2022Journal of natural products, 01-28, Volume: 85, Issue:1
Multifunctional P450 Monooxygenase CftA Diversifies the Clifednamide Pool through Tandem C-H Bond Activations.
AID1825651Antibacterial activity against Micrococcus luteus ATCC 10240 assessed as inhibition of bacterial growth measured after 18 hrs by CLSI protocol based microbroth dilution method2022Journal of natural products, 01-28, Volume: 85, Issue:1
Multifunctional P450 Monooxygenase CftA Diversifies the Clifednamide Pool through Tandem C-H Bond Activations.
AID1825652Antifungal activity against Candida albicans ATCC 48130 assessed as inhibition of fungal growth measured after 18 hrs by CLSI protocol based microbroth dilution method2022Journal of natural products, 01-28, Volume: 85, Issue:1
Multifunctional P450 Monooxygenase CftA Diversifies the Clifednamide Pool through Tandem C-H Bond Activations.
AID1424097Antibacterial activity against methicillin-resistant Staphylococcus aureus2017Journal of natural products, 04-28, Volume: 80, Issue:4
Antibacterial Compounds from Marine Bacteria, 2010-2015.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (4.35)18.2507
2000's3 (13.04)29.6817
2010's15 (65.22)24.3611
2020's4 (17.39)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.06 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index5.45 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.35%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (95.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]